Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Seek %0-9
Live
00:00
00:00
00:00
Chapters
Transcript
Video
Precision Therapy: The NCI-Match Trial
MUSC Health medical oncologist John M. Wrangle, M.D., discusses the National Cancer Institute trial, Molecular Analysis for Therapy Choice (NCIMATCH), which seeks to personalize treatment for patients with advanced cancer that has returned or worsened after standard systemic therapy. MUSC Hollings Cancer, an NCI-designated cancer center, is one of the sites for this study.
John M. Wrangle, M.D., is a board-certified medical oncologist. His clinical specialties include non-small cell lung cancer and small cell lung cancer. His medical degree was awarded by Tulane University School of Medicine. He completed ...
